CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL

Insider Sentiment (TTM):

Last Purchase:2026-03-03Last Sale:2025-08-22Shares Purchased (TTM):25Shares Sold (TTM):1,600

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:53,963,862Shares Outstanding:48,951,000Institutional Ownership Pct.:110.24%

Earnings Market Reaction:

Filing Date:2026-05-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Services-Commercial Physical & Biological Research

IQV INCY MEDP ABSI NRC OABI

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	192	214	207	183	229	195	210	179	327	277	157	200
Accounts Receivable Net Current	700	709	734	768	757	721	754	762	787	780	799	801
Inventory Net	360	299	303	280	290	279	336	349	361	380	293	285
Prepaid Expense Current	102	96	122	110	130	103	93	98	94	88	102	105
Prepaid Expense And Other Assets Current	135	129	166	130	100	106	102	111	99	83	93	113
Assets Current	1,489	1,447	1,532	1,470	1,506	1,403	1,495	1,499	1,668	1,609	1,444	1,505
Property Plant And Equipment And Finance Lease Rig…	1,510	1,655	1,592	1,607	1,587	1,604	1,640	1,614	1,619	1,640	1,525	1,530
Equity Method Investments	210	207	195	216	214	218	236	232	244	244	302	300
Operating Lease Right Of Use Asset	318	361	374	386	403	412	385	386	384	394	375	397
Goodwill	3,040	2,764	2,922	2,936	2,873	2,847	3,125	3,080	3,070	3,095	2,885	2,917
Finite Lived Intangible Assets Net	249	340	571	602	656	723	778	800	828	864	886	930
Deferred Income Tax Assets Net	89	67	37	47	49	42	38	36	37	40	34	39
Other Assets Noncurrent	826	293	291	296	294	278	307	301	303	309	155	155
Assets	7,730	7,135	7,514	7,561	7,582	7,528	8,004	7,948	8,153	8,195	7,607	7,772
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	134	149	170	146	149	140	136	133	130	169	136	140
Employee Related Liabilities Current	167	269	270	228	197	179	211	177	190	213	224	191
Contract With Customer Liability Current	194	210	238	268	250	248	252	247	256	242	250	257
Accrued Liabilities Current	372	270	229	232	242	232	208	192	191	228	198	221
Other Liabilities Current	226	222	216	207	211	194	205	198	188	203	185	199
Liabilities Current	1,094	1,120	1,122	1,080	1,051	994	1,012	948	955	1,055	994	1,008
Long Term Debt And Capital Lease Obligations	2,663	2,136	2,185	2,332	2,511	2,240	2,327	2,409	2,660	2,647	2,514	2,678
Operating Lease Liability Noncurrent	393	434	443	454	475	484	433	429	418	419	390	402
Deferred Income Tax Liabilities Net	81	95	123	109	107	107	168	165	180	191	185	207
Other Liabilities Noncurrent	511	138	189	185	196	195	237	225	235	223	173	177
Liabilities	4,742	3,924	4,063	4,161	4,341	4,020	4,176	4,175	4,449	4,536	4,256	4,472
Redeemable Noncontrolling Interest Equity Carrying…	42	41	40	40	42	41	41	46	58	57	40	42
Equity
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	1	1	1	1	1	1	1	1	1	1
Additional Paid In Capital Common Stock	1,967	1,947	2,016	1,993	1,978	1,966	1,971	1,957	1,939	1,906	1,877	1,850
Retained Earnings Accumulated Deficit	1,374	1,389	1,944	1,890	1,838	1,812	2,123	2,054	1,960	1,887	1,720	1,633
Treasury Stock Value	-	-	-	-	-	-	-	-	-	-	-24	-24
Treasury Stock Common Value	-210	0	-363	-363	-357	0	-120	-18	-9	0	-	-
Accumulated Other Comprehensive Income Loss Net Of…	-191	-172	-192	-166	-265	-317	-193	-270	-250	-196	-268	-208
Stockholders Equity	2,941	3,165	3,410	3,360	3,200	3,462	3,782	3,727	3,646	3,597	3,311	3,258
Minority Interest	6	5	5	6	6	5	5	4	6	5	5	6
Liabilities And Stockholders Equity	7,730	7,135	7,514	7,561	7,582	7,528	8,004	7,948	8,153	8,195	7,607	7,772
Allowance For Doubtful Accounts Receivable Current	8	10	14	13	16	18	24	25	25	26	21	18
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Preferred Stock Shares Authorized	20	20	20	20	20	20	20	20	20	20	20	20
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	120	120	120	120	120	120	120	120	120	120	120	120
Common Stock Shares Issued	99	98	103	103	102	102	103	103	103	103	103	103
Shares Outstanding	48	49	49	49	49	51	51	52	52	51	51	51
Treasury Stock Common Shares	1	0	2	2	2	0	1	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-0.53%	18.75%	24.71%	-	-	-	-	-	-	-	-	-
2025	-0.98%	9.52%	29.17%	8.63%	-1.18%	31.07%	6.23%	21.44%	30.95%	-1.61%	11.17%	12.42%
2024	-9.41%	-10.22%	1.47%	-1.11%	-0.83%	-8.92%	-7.07%	-13.09%	-22.98%	3.66%	-39.55%	-15.88%
2023	2.52%	7.41%	7.53%	-2.86%	-9.18%	-20.02%	14.61%	34.34%	25.18%	8.91%	3.26%	-4.75%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	1.36	1.29	1.37	1.36	1.43	1.41	1.48	1.58	1.75	1.52	1.45	1.49
Quick Ratio	0.94	0.94	0.99	1.00	1.03	1.03	1.05	1.11	1.27	1.08	1.06	1.11
Working Capital	395.10M	326.73M	410.22M	389.42M	455.30M	408.97M	482.50M	551.75M	713.38M	553.58M	450.51M	497.16M
Leverage & Debt
Debt to Equity	1.61	1.24	1.19	1.24	1.36	1.16	1.10	1.12	1.22	1.26	1.29	1.37
Interest Coverage TTM	0.66	0.24	1.26	1.07	1.48	1.80	4.01	4.16	4.19	4.52	4.70	5.60
Debt Ratio	0.61	0.55	0.54	0.55	0.57	0.53	0.52	0.53	0.55	0.55	0.56	0.58
Efficiency & Turnover
Asset Turnover TTM	0.53	0.55	0.52	0.52	0.51	0.52	0.52	0.52	0.52	0.52	0.56	0.55
Days Sales Outstanding TTM	66.02	64.98	67.52	69.30	70.03	67.65	69.82	69.95	69.92	67.74	67.97	67.62
Receivables Turnover TTM	5.53	5.62	5.41	5.27	5.21	5.40	5.23	5.22	5.22	5.39	5.37	5.40
Per Share Metrics
Diluted EPS TTM	-3.77	-2.91	-1.90	-1.64	-0.76	0.20	8.21	8.53	8.59	9.22	9.22	9.42
Free Cash Flow Per Share TTM	7.01	9.49	9.58	10.36	9.52	8.19	8.25	7.31	6.45	5.53	5.80	4.21
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	41.74%	42.35%	41.44%	41.60%	41.70%	42.08%	49.70%	47.55%	45.95%	44.40%	38.79%	41.45%
Operating Profit Margin TTM	1.75%	0.63%	3.50%	3.09%	4.38%	5.61%	13.00%	13.78%	13.99%	14.95%	15.37%	15.50%
Net Profit Margin TTM	-4.58%	-3.59%	-2.33%	-2.00%	-0.96%	0.25%	10.43%	10.85%	10.83%	11.49%	11.29%	11.60%
Growth Metrics
Net Revenue Growth (1Y)	0.11%	-0.85%	-0.92%	-1.21%	-2.16%	-1.92%	-3.67%	-2.41%	0.49%	3.86%	11.49%	13.29%
Net Income Growth (1Y)	376.83%	-1,501.75%	-122.13%	-118.23%	-108.70%	-97.83%	-10.95%	-8.76%	-10.46%	-2.39%	10.07%	9.96%
EPS Growth (1Y)	393.64%	-1,553.11%	-123.11%	-119.12%	-108.83%	-97.84%	-11.14%	-9.35%	-11.05%	-3.18%	9.18%	9.12%
Valuation Metrics
P/E TTM	-45.74	-68.50	-82.11	-92.46	-197.02	921.12	23.89	24.07	31.31	25.52	21.12	22.21
P/B TTM	2.87	3.12	2.26	2.22	2.38	2.74	2.68	2.86	3.82	3.36	3.04	3.31
P/S TTM	2.10	2.46	1.91	1.85	1.90	2.34	2.49	2.61	3.39	2.93	2.38	2.58
Market Cap	8.44B	9.89B	7.70B	7.46B	7.63B	9.48B	10.12B	10.65B	13.94B	12.11B	10.05B	10.77B
Enterprise Value	10.91B	11.81B	9.68B	9.61B	9.91B	11.52B	12.24B	12.88B	16.26B	14.47B	12.40B	13.24B
Calculated Values
Free Cash Flow TTM	343.24M	470.44M	471.61M	509.09M	482.39M	420.76M	424.01M	377.00M	331.75M	283.51M	297.57M	215.88M
Net Debt	2.46B	1.92B	1.98B	2.15B	2.28B	2.03B	2.12B	2.23B	2.32B	2.36B	2.35B	2.47B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-03Purchase

Owner: Laplume, Joseph W

Title: EVP, Corp Strategy & Develop

Shares: 25

Price/Share: $174.54

Value: $4,363.50

Shares Owned: 27,448

Relationship: Officer

Ownership: Direct

2025-08-22Sale

Owner: Laplume, Joseph W

Title: EVP, Corp Strategy & Develop

Shares: 400

Price/Share: $163.72

Value: $65,488.00

Shares Owned: 23,716

Relationship: Officer

Ownership: Direct

2025-08-18Sale

Owner: Laplume, Joseph W

Title: EVP, Corp Strategy & Develop

Shares: 800

Price/Share: $157.60

Value: $126,080.00

Shares Owned: 24,116

Relationship: Officer

Ownership: Direct

2025-08-07Sale

Owner: Laplume, Joseph W

Title: EVP, Corp Strategy & Develop

Shares: 400

Price/Share: $150.04

Value: $60,016.00

Shares Owned: 24,916

Relationship: Officer

Ownership: Direct

2025-05-15Sale

Owner: Massaro, George

Title: -

Shares: 140

Price/Share: $137.68

Value: $19,275.20

Shares Owned: 5,575

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-03	Laplume, Joseph W	Officer	EVP, Corp Strategy & Develop	Direct	Purchase	25	174.54	$4,363.50	27,448	4
2025-08-22	Laplume, Joseph W	Officer	EVP, Corp Strategy & Develop	Direct	Sale	400	163.72	$65,488.00	23,716	4
2025-08-18	Laplume, Joseph W	Officer	EVP, Corp Strategy & Develop	Direct	Sale	800	157.60	$126,080.00	24,116	4
2025-08-07	Laplume, Joseph W	Officer	EVP, Corp Strategy & Develop	Direct	Sale	400	150.04	$60,016.00	24,916	4
2025-05-15	Massaro, George	Director	-	Direct	Sale	140	137.68	$19,275.20	5,575	4
2025-05-14	Massaro, George	Director	-	Direct	Sale	140	142.38	$19,933.20	5,715	4
2025-05-13	Laplume, Joseph W	Officer	EVP, Corp Strategy & Develop	Direct	Sale	500	145.41	$72,705.00	19,513	4
2025-02-20	Girshick, Birgit	Officer	Corporate Executive VP & COO	Direct	Purchase	1,514	164.63	$249,249.82	55,058	4
2025-02-20	Laplume, Joseph W	Officer	EVP, Corp Strategy & Develop	Direct	Sale	4,400	162.50	$715,000.00	20,013	4
2025-02-20	Foster, James C	Director,Officer	Chairman, President and CEO	Direct	Purchase	6,075	165.01	$1,002,435.75	183,639	4
2024-11-07	Wallman, Richard F	Director	-	Direct	Sale	6,621	216.12	$1,430,930.52	12,386	4
2024-08-08	Laplume, Joseph W	Officer	EVP, Corp Strategy & Develop	Direct	Sale	1,780	199.36	$354,860.80	22,521	4
2024-08-01	Foster, James C	Director,Officer	Chairman, President and CEO	Direct	Sale	25,000	250.00	$6,250,000.00	188,251	4
2024-05-15	Massaro, George	Director	-	Direct	Sale	332	235.70	$78,252.40	5,855	4
2024-05-10	Laplume, Joseph W	Officer	EVP, Corp Strategy & Develop	Direct	Sale	1,304	226.97	$295,968.88	23,276	4
2024-03-08	Knell, Michael Gunnar	Officer	CSVP&Chief Accounting Officer	Direct	Sale	808	267.52	$216,156.16	7,825	4/A
2024-03-08	Knell, Michael Gunnar	Officer	CSVP&Chief Accounting Officer	Direct	Sale	808	267.52	$216,156.16	7,024	4
2024-03-04	Knell, Michael Gunnar	Officer	CSVP&Chief Accounting Officer	Direct	Sale	2,750	261.12	$718,080.00	7,832	4
2024-02-29	Creamer, Victoria L	Officer	EVP & Chief People Officer	Direct	Sale	5,000	253.70	$1,268,500.00	13,550	4
2024-02-29	Parisotto, Shannon M	Officer	CEVP, Disc & Safety Assessment	Direct	Sale	3,786	253.73	$960,621.78	4,792	4
2024-02-22	Barbo, William D	Officer	Corporate Executive VP & CCO	Indirect	Sale	4,050	248.50	$1,006,425.00	22,879	4
2024-02-15	Laplume, Joseph W	Officer	EVP, Corp Strategy & Develop	Direct	Sale	838	238.93	$200,223.34	24,620	4
2024-02-15	Parisotto, Shannon M	Officer	CEVP, Disc & Safety Assessment	Direct	Sale	5,882	241.78	$1,422,149.96	2,596	4
2023-12-14	Creamer, Victoria L	Officer	EVP & Chief People Officer	Direct	Sale	5,526	225.00	$1,243,350.00	16,506	4
2023-11-30	Laplume, Joseph W	Officer	EVP, Corp Strategy & Develop	Direct	Sale	1,850	197.73	$365,800.50	23,133	4
2023-11-20	Girshick, Birgit	Officer	Corporate Executive VP & COO	Direct	Purchase	1,322	187.82	$248,298.04	44,449	4
2023-11-14	Foster, James C	Director,Officer	Chairman, President and CEO	Direct	Purchase	5,620	178.05	$1,000,641.00	202,643	4
2023-11-09	Laplume, Joseph W	Officer	EVP, Corp Strategy & Develop	Direct	Sale	9,128	173.26	$1,581,517.28	24,983	4
2023-08-24	Wallman, Richard F	Director	-	Indirect	Purchase	1,000	198.79	$198,790.00	1,000	4
2023-08-10	Barbo, William D	Officer	Corporate Executive VP & CCO	Direct	Sale	5,763	217.24	$1,251,954.12	3,592	4
2023-08-10	Knell, Michael Gunnar	Officer	CSVP&Chief Accounting Officer	Direct	Sale	1,471	216.54	$318,530.34	9,940	4
2023-08-10	Laplume, Joseph W	Officer	EVP, Corp Strategy & Develop	Direct	Sale	700	216.52	$151,564.00	24,983	4
2023-05-15	Laplume, Joseph W	Officer	EVP, Corp Strategy & Develop	Direct	Sale	345	190.39	$65,684.55	24,026	4
2023-05-12	Laplume, Joseph W	Officer	EVP, Corp Strategy & Develop	Direct	Sale	959	193.54	$185,604.86	24,371	4
2023-05-11	Massaro, George	Director	-	Direct	Sale	288	193.43	$55,707.84	4,964	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

110.24%

Inst. Shares: 53,963,862

Shares Outstanding: 48,951,000

2025-12-31

103.12%

Inst. Shares: 51,110,899

Shares Outstanding: 49,564,000

2025-09-30

99.03%

Inst. Shares: 48,735,553

Shares Outstanding: 49,213,000

2025-06-30

107.14%

Inst. Shares: 52,655,931

Shares Outstanding: 49,149,000

2025-03-31

100.23%

Inst. Shares: 50,794,080

Shares Outstanding: 50,677,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	53,963,862	48,951,000	110.24%
2025-12-31	51,110,899	49,564,000	103.12%
2025-09-30	48,735,553	49,213,000	99.03%
2025-06-30	52,655,931	49,149,000	107.14%
2025-03-31	50,794,080	50,677,000	100.23%
2024-12-31	50,932,172	51,380,000	99.13%
2024-09-30	48,772,855	51,394,000	94.90%
2024-06-30	48,837,198	51,551,000	94.74%
2024-03-31	46,108,816	51,437,000	89.64%
2023-12-31	45,811,523	51,227,000	89.43%
2023-09-30	46,207,564	51,283,000	90.10%
2023-06-30	45,570,973	51,216,000	88.98%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) — SEC Financial Statements & Analysis

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) is a services-commercial physical & biological research company. CHARLES RIVER LABORATORIES INTERNATIONAL, INC. trades on CRL: NYSE as: CRL. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported a 0.11% year-over-year revenue growth, a Gross Profit Margin of 41.74% (TTM), a Debt-to-Equity ratio of 1.61x, a Price-to-Sales (P/S) ratio of 2.10x (TTM), a Price-to-Book (P/B) ratio of 2.87 (TTM), at a market cap of $8.44B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 0.11%
Gross Profit Margin TTM: 41.74%
Debt To Equity: 1.61x
P/S TTM: 2.10x
P/B TTM: 2.87
Market Cap: $8.44B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is CHARLES RIVER LABORATORIES INTERNATIONAL, INC. in?

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) operates in the Services-Commercial Physical & Biological Research industry.

What is CRL's market cap?

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) has a market capitalization of $8.44B as of 2026-03-31.

What exchange does CRL trade on?

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) trades on the CRL: NYSE.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.